Cargando…
Epidermal growth factor-receptor activation modulates Src-dependent resistance to lapatinib in breast cancer models
INTRODUCTION: Src tyrosine kinase overactivation has been correlated with a poor response to human epidermal growth factor receptor 2 (HER2) inhibitors in breast cancer. To identify the mechanism by which Src overexpression sustains this resistance, we tested a panel of breast cancer cell lines eith...
Autores principales: | Formisano, Luigi, Nappi, Lucia, Rosa, Roberta, Marciano, Roberta, D’Amato, Claudia, D’Amato, Valentina, Damiano, Vincenzo, Raimondo, Lucia, Iommelli, Francesca, Scorziello, Antonella, Troncone, Giancarlo, Veneziani, Bianca Maria, Parsons, Sarah J, De Placido, Sabino, Bianco, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076622/ https://www.ncbi.nlm.nih.gov/pubmed/24887236 http://dx.doi.org/10.1186/bcr3650 |
Ejemplares similares
-
Src inhibitors act through different mechanisms in Non-Small Cell Lung Cancer models depending on EGFR and RAS mutational status
por: Formisano, Luigi, et al.
Publicado: (2015) -
The dual PI3K/mTOR inhibitor PKI-587 enhances sensitivity to cetuximab in EGFR-resistant human head and neck cancer models
por: D'Amato, V, et al.
Publicado: (2014) -
Combination of a Toll-like receptor 9 agonist with everolimus interferes with the growth and angiogenic activity of renal cell carcinoma
por: Rosa, Roberta, et al.
Publicado: (2013) -
Inhibition of Hedgehog signalling by NVP-LDE225 (Erismodegib) interferes with growth and invasion of human renal cell carcinoma cells
por: D'Amato, C, et al.
Publicado: (2014) -
Urokinase-type plasminogen activator receptor (uPAR) expression enhances invasion and metastasis in RAS mutated tumors
por: Mauro, Concetta Di, et al.
Publicado: (2017)